XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net income $ 36,053 $ 29,649 $ 37,412
Adjustments to reconcile net income to net cash from operating activities      
Provision for credit losses 4,774 6,217 500
Depreciation, amortization and accretion 12,649 14,004 15,183
Compensation expense related to stock options and restricted stock awards 2,010 1,971 1,446
ESOP compensation expense for allocated shares 0 0 1,773
(Benefit) provision for deferred income taxes (693) (844) 1,750
Earnings on cash surrender value of BOLI (920) (876) (866)
Gain on sale of loans held for sale (6,711) (7,321) (30,977)
Gain on sale of portfolio loans 0 (596) (106)
Origination of loans held for sale (377,144) (566,898) (1,353,636)
Proceeds from sale of loans held for sale 411,484 708,400 1,444,305
Impairment (recovery) of MSRs 48 (1) (2,059)
(Gain) loss on sale of OREO (148) 0 9
Changes in operating assets and liabilities      
Accrued interest receivable (2,331) (3,550) (564)
Other assets (4,495) 2,127 (3,670)
Other liabilities 3,093 2,616 (1,491)
Net cash from operating activities 77,669 184,898 109,009
CASH FLOWS FROM (USED BY) INVESTING ACTIVITIES      
Maturities, prepayments, and calls 17,295 21,201 29,863
Purchases (76,030) (22,968) (130,138)
Purchases 0 (1,000) 0
Maturities of certificates of deposit at other financial institutions 4,186 5,830 1,736
Purchase of certificates of deposit at other financial institutions (23,641) 0 0
Portfolio loan originations and principal collections, net (185,024) (534,335) (214,133)
Net cash from acquisitions 336,157 0 0
Proceeds from sale of portfolio loans 0 39,034 2,699
Purchase of portfolio loans (2,818) (5,736) (1,618)
Proceeds from sale of OREO, net 718 145 81
Purchase of premises and equipment (1,671) (1,551) (1,984)
Proceeds from bank owned life insurance death benefits 0 1,169 0
Change in FHLB stock, net 8,497 (5,833) 2,661
Net cash from (used by) investing activities 77,669 (504,044) (310,833)
CASH FLOWS (USED BY) FROM FINANCING ACTIVITIES      
Net (decrease) increase in deposits (30,704) 211,935 241,537
Proceeds from borrowings 2,164,338 3,003,617 148,907
Repayments of borrowings (2,257,120) (2,859,617) (272,188)
Dividends paid on common stock (7,764) (7,096) (4,602)
Net proceeds from issuance of subordinated notes 0 0 49,333
Repayment of subordinated notes 0 0 (10,000)
Stock options exercised, net (273) 568 (2,076)
Common stock repurchased for employee/director taxes paid on restricted stock awards (355) (190) (211)
Issuance of common stock - employee stock purchase plan 1,017 503 0
Common stock repurchased (223) (15,628) (13,961)
Net cash (used by) from financing activities (131,084) 334,092 136,739
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 24,254 14,946 (65,085)
CASH AND CASH EQUIVALENTS, beginning of year 41,437 26,491 91,576
CASH AND CASH EQUIVALENTS, end of year 65,691 41,437 26,491
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION      
Interest on deposits and borrowings 38,744 10,968 8,174
Income taxes 10,396 4,693 11,083
SUPPLEMENTARY DISCLOSURES OF NONCASH OPERATING, INVESTING AND FINANCING ACTIVITIES      
Change in unrealized gain (loss) on available-for-sale investment securities 6,779 (41,849) (5,150)
Change in unrealized (loss) gain on fair value and cash flow hedges (3,814) 8,857 2,244
Retention in gross MSRs from loan sales 2,772 5,400 9,760
OREO received in settlement of loans 0 145 0
Transfer of closed retail branch to OREO 0 570 0
ROU assets in exchange for lease liabilities 2,034 3,049 979
Acquisitions:      
Assets acquired 87,512 0 0
Liabilities assumed $ 424,949 $ 0 $ 0